Resmed (RSMDF) Cash & Equivalents Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 72.43% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 21.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.48% |
| Mar 31, 2026 | 78.03% |
| Dec 31, 2025 | 171.50% |
| Sep 30, 2025 | 224.57% |
| Jun 30, 2025 | 407.40% |
| Mar 31, 2025 | 292.04% |
| Dec 31, 2024 | 148.25% |
| Sep 30, 2024 | 103.90% |
| Jun 30, 2024 | 4.59% |
| Mar 31, 2024 | 4.40% |
| Dec 31, 2023 | -16.96% |
| Sep 30, 2023 | 0.94% |
| Jun 30, 2023 | -16.74% |
| Mar 31, 2023 | 12.95% |
| Dec 31, 2022 | 30.20% |
| Sep 30, 2022 | -24.98% |
| Jun 30, 2022 | -7.30% |
| Mar 31, 2022 | -12.52% |
| Dec 31, 2021 | -23.99% |
| Sep 30, 2021 | -34.47% |